Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-19

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

The FDA approved Epic Pharma, LLC's supplemental application for amlodipine besylate, enabling a generic version of amlodipine besylate to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)